Shopping Cart No items
Call toll-free : 1-877-385-8998
Friday 15 May 2020
Myrbetriq (mirabegron) is a medication used to treat overactive bladder (OAB) in adults.
Myrbetriq's benefits include:
Given that Myrbetriq is the 191st most-prescribed medication in the U.S., it's safe to say that many patients have found it to be effective. Read on to learn more about its major benefits.
Anyone who has experienced overactive bladder can attest to the unpleasant nature of its symptoms. Rather than a disease, OAB refers to a collection of urinary symptoms. As stated by the Mayo Clinic, those symptoms include:
Unfortunately, OAB affects a large number of U.S. adults — according to the Urology Care Foundation, as many as 40 percent of men and 30 percent of women experience symptoms of OAB.
With that in mind, it's not hard to see why Myrbetriq's ability to relieve the symptoms of OAB is a significant benefit. As noted on the Myrbetriq website, clinical studies have shown that people taking Myrbetriq experienced improvement in their symptoms within the first several weeks of treatment.
Myrbetriq is unique in that it's the first and only medication in its class to target beta-3 receptors via the sympathetic nerve pathway.
Beta-3 receptors are only found in the urinary bladder, gallbladder and brown fat tissue. This means that by targeting beta-3 receptors in particular, Myrbetriq is thus able to target the bladder.
So, why beta-3 receptors? When those receptors are stimulated via Myrbetriq, the smooth muscle surrounding the bladder relaxes. In this way, the bladder is able to hold more urine, thereby allowing patients to urinate less frequently and experience fewer symptoms of urgency and leakage.
Myrbetriq was first approved by the Food and Drug Administration (FDA) for the treatment of overactive bladder in 2012. Six years later, the FDA also approved Myrbetriq to treat OAB in combination with solifenacin succinate.
Solifenacin succinate is another type of overactive bladder medication that's marketed under the brand name VESIcare, among others. Unlike Myrbetriq, solifenacin succinate works by stimulating the muscarinic receptors.
This also serves to relax the muscle surrounding the bladder, albeit via different receptors.
So by taking Myrbetriq and solifenacin succinate together, people with OAB symptoms may experience a great improvement in their symptoms than if they were taking just one of those medications alone.
OAB may be a common condition, but medications like Myrbetriq can help the millions of people who experience its symptoms.
Buy Myrbetriq online now and have it delivered straight to your door.
Weekdays: 9:00 AM - 6:00 PM PSTWeekends: 10:00 AM - 03:00 PM PST